Topical therapy with tacrolimus as an alternative therapy for seborrheic dermatitis - A pilot study;Miejscowe stosowanie takrolimusu jako alternatywna terapia łojotokowego zapalenia sköry - Badanie pilotażowe

Postepy Dermatologii i Alergologii

Volumn 24, Issue 5, 2007, Pages 211-214

  Kamińska Winciorek, Grazyna ^a   Brzezińska Wcisło, Ligia ^a  

^a Uniwersytetu Medycznego   (Poland)

Author keywords

Calcineurin inhibitor; Seborrheic dermatitis; Tacrolimus

Indexed keywords

GLUCOCORTICOID; TACROLIMUS;

APPLICATION SITE BURNING; APPLICATION SITE PRURITUS; ARTICLE; CASE REPORT; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG SAFETY; DRUG SELECTIVITY; HUMAN; OINTMENT; PILOT STUDY; SEBORRHEIC DERMATITIS; SKIN DISEASE; TREATMENT OUTCOME;

EID: 36749084714     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Brzezińska-Wcisło L. Co nowego w etiopatogenezie i leczeniu łojotokowego zapalenia skóry? Post Dermatol Alergol 2005; 1:10-3.
2. Rigopoulos D, Ioannides D, Kalogeromitros D, et al. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial. Br J Dermatol 2004; 151: 1071-5.
3. Wolska H, Błaszczyk M. Takrolimus i pimekrokimus w dermatologii. Cz. I. Leczenie atopowego zapalenia skóry. Przegl Dermatol 2004; 3: 199-208.
4. Reitamo S, Remitz A. Miejscowe leczenie immunomodulujace u chorych na atopowe zapalenie skóry. Post Dermatol Alergol 2004; 4: 159-65.
5. High WA, Pandya AG. Pilot trial of 1% pimecrolimus cream in the treatment of seborrheic dermatitis in African American adults with associated hypopigmentation. J Am Acad Dermatol 2006; 54: 1083-8.
6. Rallis E, Nasiopoulou A, Kouskoukis C, et al. Pimecrolimus cream 1% can be an effective treatment for seborrheic dermatitis of the face and trunk. Drugs Exp Clin Res 2004; 30: 191-5.
7. Wolska H, Błaszczyk M. Takrolimus i pimekrolimus w dermatologii. Cz. II. Leczenie innych niżAZS chorób skóry. Przegl Dermatol 2004; 5: 371-82.
8. Meshkinpour A, Sun J, Weinstein G. An open pilot study using tacrolimus ointment in the treatment of seborrheic dermatitis. J Am Acad Dermatol 2003; 49: 145-7.
9. Braza TJ, DiCarlo JB, Soon SL, McCall CO. Tacrokimus 0.1% ointment for seborrhoeic dermatitis: an open-label pilot study. Br J Dermatol 2003; 148: 1242-4.
10. Nagagawa H, Etoh T, Yakota Y, et al. Tacrolimus has antifungal activities against Malassezia furfur isolated from healthy adults and patients with atopic dermatitis. Clin Drug Invest 1996; 12: 245-50.
11. Furue M, Uchi H, Moroi Y, et al. Topical tacrolimus in the management of atopic dermatitis in Japan. Dermatol Ther 2006; 19: 118-26.
12. Ring J, Barker J, Behrendt H, et al. Review of the potential photo-cocarcinogenicity of topical calcineurin inhibitors: position statement of the European Dermatology Forum. J Eur Acad Dermatol Venereol 2005; 19: 663-71.
13. Fowler J. Pimecrolimus a topical calcineurin inhibitor for atopic dermatitis and other inflammatory skin diseases. Expert Rev Dermatol 2006; 3: 343-53.